Skip to main content

Table 4 Diagnostic performance of logistic regression models in differentiation of Xp11.2/TFE3 RCC from ccRCC and pRCC

From: Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma

 

AUC

Sensitivity (%)

Specificity (%)

Xp11.2/TFE3 RCC vs ccRCC

 Calcification

0.717 (0.563–0.871)

50.0 (26.0–74.0)

93.3 (83.8–98.2)

 Peak enhancement

0.836 (0.731–0.941)

88.9 (65.3–98.6)

78.3 (65.8–87.9)

 Calcification+ Peak enhancement

0.896 (0.812–0.980)

94.4 (72.7–99.9)

73.3 (60.3–83.9)

Xp11.2/TFE3 RCC vs pRCC

 Age

0.693 (0.536–0.849)

66.7 (41.0–86.7)

71.9 (53.3–86.3)

 Peak enhancement

0.708 (0.554–0.863)

66.7 (41.0–86.7)

75.0 (56.6–88.5)

 Age + Peak enhancement

0.786 (0.641–0.932)

50.0 (26.0–74.0)

100.0 (89.1–100.0)